Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (12) , 2319-2325
- https://doi.org/10.1016/j.jacc.2003.12.055
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Two novel mutations in the αIIb calcium-binding domains identify hydrophobic regions essential for αIIbβ3 biogenesisBlood, 2003
- CD40-CD40L Interactions in AtherosclerosisTrends in Cardiovascular Medicine, 2002
- Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 2001
- Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrelPlatelets, 2001
- Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive diseaseBlood Coagulation & Fibrinolysis, 2000
- The soluble CD40 ligand sCD154 in systemic lupus erythematosusJournal of Clinical Investigation, 1999
- A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN-INDUCED LETHALITYShock, 1997
- Expression of functional CD40 by vascular endothelial cells.The Journal of Experimental Medicine, 1995
- A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activationEuropean Journal of Immunology, 1995
- Inhibition of actin polymerization in blood platelets by cytochalasinsNature, 1981